Skip to main content

Day: July 2, 2025

Giga Metals Announces Proposed Debt Settlement

VANCOUVER, British Columbia, July 02, 2025 (GLOBE NEWSWIRE) — Giga Metals Corporation (TSX.V: GIGA, OTCQB: GIGGF) (the “Company“) announces that it’s proposing to settle an aggregate of approximately $63,250 in debt through the issuance of common shares to be issued at a deemed price of $0.10 per common share. Of the liabilities proposed to be settled in shares, $25,000 is payable to a former officer for management services rendered. The balance is payable to arm’s length parties. Completion of the debt settlement remains subject to the finalization of definitive documentation and the approval of the TSX Venture Exchange. About Giga Metals Corporation Giga Metals Corporation’s core asset is the Turnagain Project, located in northern British Columbia, which contains one of the few significant undeveloped sulphide...

Continue reading

Coface SA: Coface finalises the acquisition of Cedar Rose Group

Coface finalises the acquisition of Cedar Rose Group Paris, 2 July 2025 – 17.35 Coface announces the closing of the acquisition of Cedar Rose Group, a leader in Information Services in the Middle East. With over 25 years’ experience, Cedar Rose is one of the leading providers of business information solutions in the Middle East and Africa region. In a region where information is difficult to access and with positive economic growth outlook, Cedar Rose has built up a vast business network enabling it to produce data whose quality is recognised by its customers, including a number of multinationals. Cedar Rose therefore becomes Coface’s information provider in the region, for both credit insurance and Information Services sales. All Coface’s customers will benefit from enhanced Coface data. This external growth operation...

Continue reading

I-Mab Presents Positive Givastomig Phase 1b Dose Escalation Data in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers at ESMO GI 2025

Data show confirmed ORR of 83% (10/12) at doses selected for ongoing expansion study Median follow-up of 9.0 months as of the updated data cutoff Responses observed in patients with low PD-L1 and/or CLDN18.2 expression Company to host investor event on Tuesday, July 8th ROCKVILLE, Md., July 02, 2025 (GLOBE NEWSWIRE) — I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced the presentation of positive Phase 1b combination data for givastomig, in combination with nivolumab and mFOLFOX6, at the European Society for Medical Oncology Gastrointestinal Cancers Congress 2025 (ESMO GI 2025) in Barcelona (abstract #388MO). Givastomig is a bispecific antibody targeting Claudin 18.2 and 4-1BB. I-Mab plans to host...

Continue reading

SKYX Announces 8 Newly Issued U.S. and Global Patents With Now Over 100 Patents and Pending Applications With 45 Issued Patents

SKYX New Patents Were Issued in the U.S., India, Japan, U.K. France, Germany, Italy, and Spain SKYX’s Patent Portfolio Includes Advanced Plug & Play Smart Home Platforms, Enabling AI Capabilities and Eco System Integration, Home Safety Sensors, Ceiling Fan & Heater, Lighting, Among Others MIAMI, July 02, 2025 (GLOBE NEWSWIRE) — SKYX Platforms Corp. (NASDAQ: SKYX) (“SKYX” or the “Company”), a highly disruptive smart home platform technology company with over 100 issued and pending patents globally and a growing portfolio of over 60 lighting and home décor websites, with a mission to make homes and buildings become smart, safe, and advanced as the new standard, today announces the issuance of 8 newly issued U.S. and global patents with now over 100 patents and pending applications with 45 issued patents. The new patents...

Continue reading

Form 8.3 – [MARLOWE PLC – 30 06 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree MARLOWE PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Application for delisting

In connection with the planned completion of the takeover of the shares belonging to minority shareholders in accordance with the resolutions of the general meeting of shareholders held on 26 June 2025 (link to the minutes of the general meeting, in Estonian), the Management Board of Enefit Green submitted today, on 2 July 2025, an application for the delisting of the shares of Enefit Green to the Listing and Supervision Committee of Nasdaq Tallinn. On or about 28 July 2025, the Management Board of Enefit Green will submit an application to the registrar of the register of securities for the transfer of the shares belonging to minority shareholders to Eesti Energia AS simultaneously with the payment of the compensation payable to minority shareholders (€3.40 per share).Further information:Sven KunsingHead of Finance Communicationsin...

Continue reading

Intuitive’s da Vinci 5 Surgical System Receives CE Mark

Fifth-generation da Vinci surgical system approved for use in Europe across multiple procedures SUNNYVALE, Calif., July 02, 2025 (GLOBE NEWSWIRE) — Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the da Vinci 5 Surgical System has received CE mark approval for adult and pediatric use in Europe for minimally invasive endoscopic procedures across abdominopelvic and thoracoscopic surgical procedures, including urologic, gynecologic, and general laparoscopic procedures. Da Vinci 5 is Intuitive’s most advanced and integrated multiport robotic-assisted surgical system, building on the da Vinci Xi Surgical System’s highly functional design. It features more than 150 enhancements and joins a portfolio of da Vinci surgical systems that surgeons...

Continue reading

Music Licensing, Inc. (OTC: SONG) Announces Plans to Engage PCAOB-Registered Audit Firm for Annual Audits and Future Financial Statement Reviews

NAPLES, FL, July 02, 2025 (GLOBE NEWSWIRE) — Music Licensing, Inc. (OTC: SONG), also known as Pro Music Rights, a diversified holding company and the fifth public performance rights organization (PRO) established in the United States, today announced that it is actively pursuing the engagement of a Public Company Accounting Oversight Board (PCAOB)-registered audit firm to conduct annual audits and provide ongoing reviews of its financial statements. This initiative marks a significant step in strengthening the company’s financial reporting infrastructure and reinforces its long-term commitment to transparency, regulatory compliance, and best practices in corporate governance. The company believes that the engagement of a PCAOB-registered firm will provide independent assurance regarding the accuracy and completeness of its financial...

Continue reading

WORLDLINE commits to robustness

Worldline commits to robustnessTwo external firms engaged to assess risk framework and audit remaining HBR portfolio Paris La Défense, 2 July 2025 – Worldline [Euronext: WLN], a global leader in payment services, announces it has initiated two external assessments to evaluate its risk management framework. As part of a commitment to full transparency and to dissipate any residual doubt, an audit has been commissioned to Accuracy on the remaining High Brand Risk (HBR) portfolio to confirm its clean-up and alignment with its compliance and risk framework. Additionally, Worldline will undertake a comprehensive assessment of its compliance and risk framework and its implementation, a task assigned to Oliver Wyman. The main conclusions will be communicated alongside the Group earnings report on October 21st and the first outcomes will be communicated...

Continue reading

Aeries Technology, Inc. Reports Results for the Full Fiscal Year 2025

Beats Core Adjusted EBITDA Guidance, North America Revenue Up 15% Year-Over-Year NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) — Aeries Technology, Inc. (“Aeries” or “the Company”) (Nasdaq: AERT), a global leader  in AI-enabled value creation, business transformation, and Global Capability Center (GCC) delivery for private equity (PE) portfolio companies, today announced financial results for the fiscal year ended March 31, 2025.   As previously communicated, Aeries will discontinue reporting Core Adjusted EBITDA as a financial metric beginning in FY2026. With the company now fully focused on core operations, Adjusted EBITDA and GAAP results will continue to be reported to provide information on the Company’s operating performance. Ajay Khare, Chief Executive Officer of Aeries, commented, “We began the year forecasting $6–7 million...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.